The CP block (CPB) and neurolysis (CPN), first described in 1914 by Kappis [10], have been used for decades in human analgesia to treat pain associated with chronic pancreatitis and abdominal malignancies such as pancreatic cancer [1]. This evidence concerns the gene CP and pancreatic neoplasm.